Tag Archives: 215758

AN UPDATE: India – Natco – Compulsory license

This is an update of Natco’s compulsory license application for Sorafenib and continuation of the earlier post. Controller of patent posted this CL opposition hearing on Jan 06, 2012. (DNA article). Bayer/patentee has sought for adjournment of this hearing (copy of … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | Leave a comment